Compound Global Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-100
Closed -$50.1K – 42
2026
Q2
$50.1K Buy
+100
New +$48K 1.24% 25
2024
Q1
– Sell
-11,053
Closed -$5.87M – 46
2023
Q4
$5.87M Sell
11,053
-2,937
-21% -$1.42M 1.09% 34
2023
Q3
$7.08M Sell
13,990
-7,936
-36% -$4.23M 1.55% 28
2023
Q2
$11.4M Buy
21,926
+7,639
+53% +$4.12M 2.64% 16
2023
Q1
$8.23M Hold
14,287
– – 2.09% 23
2022
Q4
$7.87M Buy
+14,287
New +$7.57M 2.24% 22

Other funds holding TMO

Compound Global Advisors's TMO Position: Q3 2026 in Review

Compound Global Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2026, closing a stake of 100 shares — an estimated $50.1K sold.

Compound Global Advisors first reported a position in TMO in Q4 2022 and held it in 6 quarters. The position peaked at $11.4M in Q2 2023. 813 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Compound Global Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2026 after selling out during the quarter.
  • Compound Global Advisors sold 100 Thermo Fisher Scientific shares in Q3 2026, an estimated $50.1K.
  • Compound Global Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 6 quarters.
  • Compound Global Advisors's Thermo Fisher Scientific position peaked at $11.4M in Q2 2023.
  • 813 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Compound Global Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.